These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 7785023)

  • 1. Co-amoxiclav levels in bronchial mucosa.
    Honeybourne D; Andrews JM; Wise R
    Thorax; 1995 Apr; 50(4):429. PubMed ID: 7785023
    [No Abstract]   [Full Text] [Related]  

  • 2. Penetration of amoxycillin/clavulanic acid into bronchial mucosa with different dosing regimens.
    Gould IM; Harvey G; Golder D; Reid TM; Watt SJ; Friend JA; Legge JS; Douglas JG
    Thorax; 1994 Oct; 49(10):999-1001. PubMed ID: 7974318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous determination of amoxycillin and clavulanic acid in pharmaceutical products by HPLC with beta-cyclodextrin stationary phase.
    Tsou TL; Wu JR; Young CD; Wang TM
    J Pharm Biomed Anal; 1997 May; 15(8):1197-205. PubMed ID: 9215973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stability of amoxicillin-clavulanate in BACTEC medium determined by high-performance liquid chromatography and bioassay.
    Moore TD; Horton R; Utrup LJ; Miller LA; Poupard JA
    J Clin Microbiol; 1996 May; 34(5):1321-2. PubMed ID: 8727931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amoxycillin/clavulanic acid levels in lower respiratory secretions.
    Gould IM; Legge JS; Reid TM
    J Antimicrob Chemother; 1988 Jul; 22(1):88-90. PubMed ID: 3170397
    [No Abstract]   [Full Text] [Related]  

  • 6. Severe penicillin allergy precipitated by inhalation and topical exposure to co-amoxiclav (Augmentin).
    Jarrett P; Rademaker M
    N Z Med J; 1996 Sep; 109(1030):366. PubMed ID: 8890865
    [No Abstract]   [Full Text] [Related]  

  • 7. Antibiotic persistence and tolerance in the lactating sheep following a course of intramammary therapy.
    Buswell JF; Barber DM
    Br Vet J; 1989; 145(6):552-7. PubMed ID: 2590825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resistance to amoxicillin/clavulanate in Escherichia coli.
    Colaert J
    Acta Clin Belg; 1992; 47(5):353-4. PubMed ID: 1334324
    [No Abstract]   [Full Text] [Related]  

  • 9. Cholestatic hepatitis after therapy with amoxicillin/clavulanate potassium.
    Schneider JE; Kleinman MS; Kupiec JW
    N Y State J Med; 1989 Jun; 89(6):355-6. PubMed ID: 2739957
    [No Abstract]   [Full Text] [Related]  

  • 10. Resistance to amoxicillin/clavulanate in Escherichia coli.
    Glupczynski Y; Mac Gillavry G; Yourassowsky E
    Acta Clin Belg; 1992; 47(5):354-5. PubMed ID: 1334325
    [No Abstract]   [Full Text] [Related]  

  • 11. [Cholestatic hepatitis from amoxicillin-clavulanic acid].
    Cabelleria Rovira E; Masso Ubeda RM; Arago López JV; Sanchís Closa A
    An Med Interna; 1992 Jul; 9(7):360-1. PubMed ID: 1633249
    [No Abstract]   [Full Text] [Related]  

  • 12. Amoxycillin with clavulanic acid.
    Toh C
    Aust Nurses J; 1989; 18(6):23. PubMed ID: 2912437
    [No Abstract]   [Full Text] [Related]  

  • 13. [Cholestatic hepatitis caused by a combination of amoxicillin and clavulanic acid (Augmentin)].
    van den Broek JW; Buennemeyer BL; Stricker BH
    Ned Tijdschr Geneeskd; 1988 Aug; 132(32):1495-7. PubMed ID: 3173514
    [No Abstract]   [Full Text] [Related]  

  • 14. [The pharmacokinetics, dosage, tolerance, side effects and safety of the preparation Augmentin (a combination of amoxicillin and clavulanic acid)].
    Robinson OP
    Antibiot Khimioter; 1992 Sep; 37(9):20-3. PubMed ID: 1444662
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparative evaluation of the clinical and microbiological efficacy of co-amoxiclav vs cefixime or ciprofloxacin in bacterial exacerbation of chronic bronchitis.
    Cazzola M; Vinciguerra A; Beghi GF; Paizis G; Giura R; Madonini V; Fiorentini F; Consigli GF; Tonna M; Casalini A
    J Chemother; 1995 Oct; 7(5):432-41. PubMed ID: 8596127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholestatic hepatitis associated with clavulanic acid.
    Ryan J; Dudley F
    Gut; 1992 Nov; 33(11):1583. PubMed ID: 1452090
    [No Abstract]   [Full Text] [Related]  

  • 17. Cholestatic hepatitis associated with amoxicillin-clavulanate.
    Belknap MK; McClelland KJ
    Wis Med J; 1993 May; 92(5):241-2. PubMed ID: 8328159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The development of bacterial resistance and the role of clavulanic acid].
    Rolinson JN
    Antibiot Khimioter; 1992 Sep; 37(9):11-4. PubMed ID: 1444658
    [No Abstract]   [Full Text] [Related]  

  • 19. Co-amoxiclav in recurrent acute otitis media: placebo controlled study.
    Appelman CL; Claessen JQ; Touw-Otten FW; Hordijk GJ; de Melker RA
    BMJ; 1991 Dec; 303(6815):1450-2. PubMed ID: 1773154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of azithromycin and co-amoxiclav in the treatment of acute tracheobronchitis and acute infectious exacerbations of chronic bronchitis in adults. Azithromycin Study Group.
    Biebuyck XA
    J Int Med Res; 1996; 24(5):407-18. PubMed ID: 8895044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.